Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2014121195
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2018English

C3 Glomerulopathy

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy

Frontiers in Immunology
AllergyImmunology
2018English

Factor B and C4b2a Autoantibodies in C3 Glomerulopathy

Frontiers in Immunology
AllergyImmunology
2019English

Effect of Complement Component C3 Deficiency on Experimental Lyme Borreliosis in Mice

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2003English

Glomerular Complement Factor H Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment

Kidney International Reports
Nephrology
2019English

Membranoproliferative Glomerulonephritis and C3 Glomerulopathy: Resolving the Confusion

Yearbook of Pathology and Laboratory Medicine
2013English

Statistical Validation of Rare Complement Variants Provides Insights Into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy

Journal of Immunology
AllergyImmunology
2018English

Complement in Experimental Autoimmune Encephalomyelitis Revisited: C3 Is Required for Development of Maximal Disease

Molecular Immunology
ImmunologyMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy